Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Aprepitant in the Management of Biological Therapies-related Severe Pruritus (AprepIt)

This study has been completed.
Information provided by (Responsible Party):
Daniele Santini, Campus Bio-Medico University Identifier:
First received: September 5, 2012
Last updated: September 11, 2012
Last verified: September 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2011
  Primary Completion Date: November 2011 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):